Influence of an essential fatty acid deficient diet on absorption of topical hydrocortisone in the rat. 1987

B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
Centre International de Recherches Dermatologiques, Sophia Antipolis, Valbonne, France.

Using a rat dermatosis model, produced by dietary essential fatty acid deficiency (EFAD), which is characterized by histological changes and elevated transepidermal water loss, changes in skin permeability were studied using [14C]-hydrocortisone (HC). Skin, serum and urinary levels of HC were measured, and absorption and excretion of HC in EFAD rats compared with that in control rats on a normal diet. This animal model has demonstrated the importance of the functional integrity of the horny layer in skin penetration.

UI MeSH Term Description Entries
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005228 Fatty Acids, Essential Long chain organic acid molecules that must be obtained from the diet. Examples are LINOLEIC ACIDS and LINOLENIC ACIDS. Acids, Essential Fatty,Essential Fatty Acids
D005260 Female Females
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012869 Skin Absorption Uptake of substances through the SKIN. Absorption, Skin,Intracutaneous Absorption,Intradermal Absorption,Percutaneous Absorption,Transcutaneous Absorption,Transdermal Absorption,Absorption, Intracutaneous,Absorption, Intradermal,Absorption, Percutaneous,Absorption, Transcutaneous,Absorption, Transdermal,Absorptions, Intracutaneous,Absorptions, Intradermal,Absorptions, Percutaneous,Absorptions, Skin,Absorptions, Transcutaneous,Absorptions, Transdermal,Intracutaneous Absorptions,Intradermal Absorptions,Percutaneous Absorptions,Skin Absorptions,Transcutaneous Absorptions,Transdermal Absorptions

Related Publications

B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
January 1985, Reproduction, nutrition, developpement,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
May 1973, Archives of oral biology,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
January 1990, Pharmacological research,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
February 1987, Prostaglandins,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
November 1973, The Journal of nutrition,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
September 1997, Journal of lipid research,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
August 1990, Metabolism: clinical and experimental,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
November 1981, The Journal of laboratory and clinical medicine,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
July 1977, The British journal of dermatology,
B Lambrey, and W Schalla, and N Kail, and J P Lahmy, and H Schaefer
June 1988, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!